Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Biology in Clinical Oncology Workshop
Block Grants for Community Mental Health Services
Csf 1 in Mammary Gland Growth and Development
Scientific and Technical Evaluation Award
Opus: a Synthesis of Five Decades of Biogeochemical Research in A Northern Hardwood Forest Ecosystem
Recently added grants:
Innate Immune Regulation by HSF1 in Liver Inflammatory Injury
A structure-based approach to accelerated recombinase engineering
Novel carbohydrate binding functions of the CR3 I-domain modulate gonococcal-cervical cell interactions
Molecular mechanism of antigen editing by Class-I MHC Chaperones
Genetic mechanisms of snail/schistosome compatibility
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67189-3-0-1
Application #
7574874
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Howard University
$308,392
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gordeuk, Victor /
$263,550
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant